Parkside Financial Bank & Trust’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432 Buy
+90
New +$543 ﹤0.01% 2620
2026
Q1
– Sell
-75
Closed -$782 – 2771
2025
Q4
$782 Sell
75
-500
-87% -$5.02K ﹤0.01% 2420
2025
Q3
$5.16K Buy
575
+75
+15% +$658 ﹤0.01% 1725
2025
Q2
$6.49K Sell
500
-30
-6% -$451 ﹤0.01% 1624
2025
Q1
$13.4K Buy
530
+30
+6% +$892 ﹤0.01% 1301
2024
Q4
$17.2K Hold
500
– – ﹤0.01% 1129
2024
Q3
$24.7K Buy
+500
New +$25.6K ﹤0.01% 999

Other funds holding RXST

Parkside Financial Bank & Trust's RXST Position: Q2 2026 in Review

Parkside Financial Bank & Trust opened a new position in RxSight (RXST) in Q2 2026: 90 shares worth $432. The stake represents ﹤0.01% of the portfolio and ranks #2620 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in RXST as recently as Q4 2025.

Parkside Financial Bank & Trust first reported a position in RXST in Q3 2024 and has held it in 7 quarters since. The position peaked at $24.7K in Q3 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Parkside Financial Bank & Trust held 90 shares of RxSight worth $432 as of Q2 2026.
  • RxSight was a new Parkside Financial Bank & Trust position in Q2 2026.
  • RxSight made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2620 holding.
  • Parkside Financial Bank & Trust first reported a position in RxSight in Q3 2024 and has held it in 7 quarters since.
  • Parkside Financial Bank & Trust's RxSight position peaked at $24.7K in Q3 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.